OFFICIAL STATEMENT

marketing@lepu-medical.com Investors

Global-en

Products

Cardiovascular and Peripheral Products Cardiac Rhythm Management Products Digital Subtraction Angiography Systems Critical Care Products Hemodialysis Products In Vitro Diagnostic Products ECG & Patient Monitor & Telehealth Solutions Pharmaceutical (API) Products Surgical Products Structural Heart Diseases Products Orthopedic Products Skin Care

PTCA Balloon NC Balloon Others

Dialyzers Bloodline and Fistula Needle

Colloidal Gold Quantitative Analyzer SARS-CoV-2 Test Kits 2019-nCoV Neutralization Antibody Test Kit Poctor® blood glucose, ketone body, uric acid detector Cholesterol Analyzer PT/INR Meter Immunofluorescence Quantitative Analyzer
Fully Automated ELISA workstation Fully Automated CLIA workstation Automatic fluorescence immunoassay analyzer
Fully Automated Nucleic Acid Extractor Nucleic Acid Extraction or Purification Kit Real-Time PCR System
Thromboelastography Analyzer Fully automated blood grouping system
Other Platforms

Others

Solutions

PCI Solution Hemodialysis Solution Orthopedic and Surgical In-Hospital and Out-of-Hospital Solution

Services

About Us

About Us Join Us

News

News Events Center Customer Stories PR

Investor

Contact Us

Home>News

OFFICIAL STATEMENT

2023-08-03

LEPU

OFFICIAL STATEMENT

appendix-iv-official-statement.pdf

How to Choose the Right Guidewire Medical Device

How to Read a Vital Signs Monitor?

I agree to use and transfer my personal information in accordance with LEPU MEDICAL's privacy policy. Submit

Top